Tumor metastasis is still the leading cause of melanoma mortality. Luteolin, a natural flavonoid, is found in fruits, vegetables, and medicinal herbs. The pharmacological action and mechanism of luteolin on the metastasis of melanoma remain elusive. In this study, we investigated the effect of luteolin on A375 and B16-F10 cell viability, migration, invasion, adhesion, and tube formation of human umbilical vein endothelial cells. Epithelialmesenchymal transition (EMT) markers and pivotal molecules in HIF-1α/VEGF signaling expression were analysed using western blot assays or quantitative real-time polymerase chain reaction. Results showed that luteolin inhibits cellular proliferation in A375 and B16-F10 melanoma cells in a time-dependent and concentration-dependent manner.
also plays a key role in the development, growth, and migration of melanoma cells and may also facilitate pathways for dissemination during the process of metastasis (Wang et al., 2015) . Vascular endothelial growth factor (VEGF) and related VEGF receptors have a central role in the modulation of pathological angiogenesis (Ni et al., 2012) . Furthermore, VEGF binds to its receptor activating VEGFR2, which further leads to the secretion of matrix metalloproteinases (MMPs), resulting in the degradation of extracellular matrix (ECM) and provision of passage for cells to invade the nearby tissue. MMP-2 and MMP-9 are closely related to the migratory and invasive ability of cancer cells and present in various malignant tumors (Botti et al., 2013) . In addition, VEGF is the key downstream effector of hypoxia-inducible factor-1α (HIF-1α) and plays key roles in inducing cell migration, proliferation, and tube formation with a unique specificity for endothelial cells. Moreover, HIF-1α was shown to induce EMT in many types of cancer tissues. HIF-1α expression profile was correlated with the expression levels of E-cadherin, N-cadherin, and vimentin (Lai et al., 2016) . Based on these findings, HIF-1α/VEGF signal pathway is considered to be an important target for the treatment of angiogenesis-related diseases including metastasis of cancer.
Luteolin (3′, 4′, 5, 7-terahydroxyflavone) is a common effective dietary flavonoid that is present in fruits, vegetables, and medicinal herbs (Liu, Xu, Yan, Cheng, & Liu, 2018; Song et al., 2017) . Furthermore, accumulating evidences have suggested that luteolin possesses multiple pharmacological activities such as anti-inflammation, antihypertension, antioxidant, and antitumor, which are also supposed to be the basis of these biological properties (Aziz, Kim, & Cho, 2018; Cui et al., 2017) . Previous studies indicate that luteolin suppress cancer cell growth through multiple mechanisms including promoting cancer cell apoptosis and cell cycle arrest, inhibiting cell proliferation and tumor growth, improving drug resistance, and mitigating invasiveness and metastasis of cancer cells (Cook, Liang, Besch-Williford, & Hyder, 2017; Wang et al., 2014) . Specifically, it has been found that luteolin inhibited the tumor formation in vivo through its antioxidant and anti-inflammatory activity (Hwang, Lee, Kim, & Hwang, 2013) . Furthermore, luteolin effectively blocked progestin-dependent angiogenesis and the stem cell-like phenotype in human breast cancer cells (Cook, 2018) . Although these studies revealed luteolin's protective roles in cancer, the effects and underlying mechanisms of luteolin on the metastasis of melanoma have not been reported previously.
Therefore, in the present study, we evaluated the effects of luteolin on A375 and B16-F10 cell viability, migration, invasion, adhesion, and tube formation of human umbilical vein endothelial cells (HUVECs). Concurrently, the underlying molecular mechanism of luteolin anti-metastasis were investigated in association with inhibition of HIF-1α/VEGF signaling pathway and the resulting decreased EMT and angiogenesis. Luteolin (99.9% purity, was purchased from Ark Pharm, Inc. (Illinois, USA) and was dissolved in dimethyl sulfoxide (DMSO, Sigma, St Louis, MO, USA) as 100-mM stock solution (stored at 4°C) for experiments. 3-(4,5-dimethyl-2-thiazoyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) and LY294002 (PI3K inhibitor) were obtained from Sigma-Aldrich (St Louis, MO, USA). Dulbecco's modified eagle's medium (DMEM), fetal bovine serum (FBS), and penicillin/streptomycin were purchased from Gibco (Thermo Fisher Scientific Inc, USA). Antibodies against E-cadherin (mouse; cat. no. 14472), N-cadherin (rabbit; cat. no. 13116), and vimentin (mouse; cat. no. 3390) were purchased from Cell Signaling Technology (Cambridge, MA, USA). Primary antibodies to Akt (rabbit; cat. no. ab235958), p-Akt (rabbit; phosphor S473, cat. no. ab81283), HIF-1α (rabbit; cat. no. ab51608), VEGF-A (rabbit; cat. no. ab46154), VEGFR-2 (rabbit; cat. no. ab2349), p-VEGFR-2(rabbit; phosphor Y951, cat. no. ab38473), MMP-2 (rabbit; cat. no. ab37150), MMP-9 (rabbit; cat. no. ab73734), and β-actin (rabbit; cat. no. ab8227) were purchased from Abcam (Cambridge, MA, USA). Goat anti-mouse IgG-HRP (cat. no. sc-2005) and goat anti-rabbit IgG-HRP (cat. no. sc-2004) were purchased from Santa Cruz Biotechnology (Dallas, TX, USA).
| MATERIALS AND METHODS

| Reagents and cell culture
Human melanoma A375 obtained from American Type Culture Collection (ATCC, Manassas, VA, USA). Mouse melanoma B16-F10 and HUVECs were purchased from the Cell Culture Center of Chinese Academy of Medical Sciences (Beijing, China). The cells were cultured in DMEM containing 10% FBS, 100-U/mL penicillin, and 100-μg/mL streptomycin. Hypoxia was induced by exposing the cells to cobalt chloride (CoCl 2, Sigma-Aldrich, St. Louis, MO, USA). Cells were seeded into 6-well plates at a density of 1 × 10 5 /well. After 90% confluence was reached, they were treated with CoCl 2 at concentration 100 μM in DMEM medium with 0.5% FBS for 24 hr (Tatrai et al., 2017) . All cell cultures were maintained at 37°C in a humidified atmosphere of 5% CO 2 .
| Cell viability assay
Cell viability was determined by MTT assay to investigate the cytotoxic effect of luteolin in vitro (Corina et al., 2017) . A375 and B16- 
| Wound-healing assay
Cell migration was measured by wound-healing assay to evaluate the inhibit migration effect of luteolin in vitro (Si et al., 2018) . A375 and B16-F10 cells were seeded in 60-mm dishes at the density of 8 × 10 5 cells per dish to 90-100% confluence. In the center of each dish, a denuded zone was carefully created by scraping the cell monolayer with pipette tip. After wounding with pipette tip, the cells were washed with phosphate buffered saline, and serum-free medium containing various concentrations (5, 10, and 20 μM) of luteolin had been added. Then, the cells were allowed to migrate for 24 hr. At predetermined time points (0, 3, 6, 9, 12, and 24 hr), the widths of wound were measured, and images of cells that migrated into the wounded region were captured at time 0 and 24 hr using an inverted microscope (IX71, Olympus, Tokyo, Japan).
| Transwell invasion assay
Cell invasion was detected using Matrigel-coated transwell chambers (8 μm pore size; Corning, USA) assay according to the manufacturer's instructions (Si et al., 2018) 
| Cell adhesion assay
After pretreatment with or without ( 
| Tube formation assay
The HUVECs capillary-like formation assay was performed on Matrigel 
| Quantitative real-time polymerase chain reaction
After pretreatment with or without (control) various concentrations (5, 10, and 20 μM) of luteolin for 24 hr, the total RNA of A375 and B16- 
| Western blotting assay
Western blotting assay was used for detection of E-cadherin, N- 
| Statistical analyses
Statistical analysis was performed using SPSS 19.0 (Chicago, IL, USA).
All data are presented as the mean ± standard deviation (SD).
One-way analysis of variance test was utilized to analyze the difference between the groups. The least significant difference and Tukey method were utilized to analyze post hoc multiple comparisons. P values were two-sided; p < 0.05 was considered to indicate a statistically significant difference.
| RESULTS
| Luteolin-inhibited viability of A375 and B16-F10 cells
Luteolin has a molecular weight of 286.24 g/mol, and its molecular structure is shown in Figure 1a . Firstly, we measured the inhibitory effects of luteolin on the viability of melanoma cells A375 and B16-F10 by MTT assay. Figure 1b, 
| Luteolin inhibited the migratory potential of A375 and B16-F10 cells
Cell migration is essential step in cancer metastasis. As shown in , and 20 μM) of luteolin for 24 hr. Then, the inhibitory effects of luteolin on A375 and B16-F10 cell migration was evaluated by wound-healing assay. Images were taken at 0 and 24 hr after the wound scratch area was made under the invert microscope (100× magnification). The scale in the figure is 100 μm. The migration distance was measured by the scale of microscope. Values are the means ± SD from three independent determinations. *p < 0.05 and **p < 0.01 indicate a significant difference from the control group being able to completely heal the wound scratch. The activity of migration of A375 and B16-F10 cells was markedly suppressed by luteolin in a concentration-dependent manner. 
| Luteolin inhibited the invasion of A375 and B16-F10 cells
| Luteolin inhibited A375 and B16-F10 cells adhesion
Adhesion of cancer cells to components of the ECM is an essential step for cancer metastasis. Therefore, we measured the effect of luteolin on cell adhesion. In the absence of luteolin (control group), A375 and B16-F10 cells displayed high adhesive capabilities as indicated by being able to completely adhere to the fibronectin (Figure 4a,b) . These data revealed that luteolin markedly suppresses A375 and B16-F10 cells activity of adhesion in a concentration-dependent manner (Figure 4a,b) .
| Luteolin inhibited the tube formations of HUVECs cells in vitro
Angiogenesis, the key step in tumor growth and metastasis, provides the necessary oxygen and nutrients for tumor and may also facilitate pathways for dissemination during the process of metastasis. To investigate the effect of luteolin on angiogenesis in vitro, the capillary tube formation of HUVECs cells on Matrigel was performed. As shown in Figure 5 a,b, the capillary tube formation of HUVECs cells was markedly inhibited after 24 hr exposure to luteolin when compared with the control group.
These results indicated that luteolin had a concentration-dependent inhibitory effect on the tube formation of HUVECs cells in vitro.
| Luteolin suppressed protein and gene expression of EMT typical markers in A375 and B16-F10 cells
Accumulating evidence indicates that metastasis is a programmed multistep process. EMT is one purported mechanism linked to tumor 
| DISCUSSION
Metastatic spread is still the leading cause of the melanoma death.
Metastasis is a programmed multistep process, including cell migration, invasion, and adhesion. The exploration of effective natural , and 20 μM) of luteolin for 24 hr. Capillary tube formation was assessed after 6 hr. Images were taken, and the total number of nodes and branches were calculated under a phase-contrast microscope with 200× magnitudes. The scale in the figure is 100 μm. Values are the means ± SD from three independent determinations. *p < 0.05 and **p < 0.01 indicate a significant difference from the control group compounds targeting EMT and angiogenesis have been the efficient therapeutic approach for the treatment of metastatic cancers . Luteolin, a flavonoid that is found in more than 300 plant species, has recently been shown to inhibit a variety of cancers, both in vitro and in vivo, with little to minimal toxicity (Lu et al., 2015; Ruan et al., 2012) . Previous studies have shown that luteolin inhibits metastasis of triple-negative breast cancer cells through suppressing EMT (Cook et al., 2017) . Recent studies have validated the association between the metastasis potential of cancer cells and the activation of the EMT (Yi et al., 2018) . Actually, the suppression of EMT is emerging as a common mechanism underlying the inhibitory effect on metastasis potential of cancer cells (Ryu et al., 2017) . Tumor angiogenesis is another physiological process essentially required for tumor progression and metastasis (Shi, Chen, Wang, Guo, & Wang, 2018) . Although increasing evidence indicates that angiogenesis is a highly sophisticated and coordinated process, the activation of a hypoxic-induced factor (HIF) growth factor pathway remains the key modulator (Martinez-Garcia et al., 2017) . Tumor tissue is usually accompanied by hypoxia, which promotes HIF production. HIF-1 is a dimeric transcription factor composed of the HIF-1α
and HIF-1β subunits. HIF-1α is rapidly degraded under normoxic conditions and stabilized under hypoxia, whereas HIF-1β is expressed constitutively. HIF-1α has been correlated with tumor grade, metastasis, and poor prognostic outcomes in various cancers (Mouriaux et al., 2014) . In addition, HIF-1α was shown to induce EMT in many types of cancer tissues. HIF-1α expression profile was correlated with the expression levels of E-cadherin, N-cadherin, and vimentin. VEGF binds In summary, this study is of significant importance as currently limited therapeutic options are available for highly metastatic melanoma patients. Importantly, we found that luteolin inhibited melanoma cell migration, invasion, adhesion, and capillary tube formation abilities by inhibiting the HIF-1α/VEGF signaling pathway. We propose that luteolin possesses a strong therapeutic potential against highly metastatic melanoma cells and could be an effective supplement for patients, and more detailed investigation regarding its mechanism of action and clinical trials involving its use are warranted.
